Investigation Overview
September 30, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Nektar Therapeutics (NASDAQ:NKTR) shares over potential securities laws violations by Nektar Therapeutics and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the ...
You must register (for free) or login to view the entire investigation.